1. Home
  2. BGLC vs DKI Comparison

BGLC vs DKI Comparison

Compare BGLC & DKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$2.20

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

DKI

DarkIris Inc. Class A Ordinary Shares

N/A

Current Price

$0.34

Market Cap

8.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
BGLC
DKI
Founded
2017
2018
Country
Malaysia
Hong Kong
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
8.7M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BGLC
DKI
Price
$2.20
$0.34
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.5K
51.9K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
45.78
N/A
EPS
N/A
N/A
Revenue
$9,510,646.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.92
$0.28
52 Week High
$15.19
$11.80

Technical Indicators

Market Signals
Indicator
BGLC
DKI
Relative Strength Index (RSI) 41.29 42.74
Support Level $2.12 $0.31
Resistance Level $2.73 $0.48
Average True Range (ATR) 0.11 0.03
MACD -0.02 -0.00
Stochastic Oscillator 12.55 43.79

Price Performance

Historical Comparison
BGLC
DKI

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About DKI DarkIris Inc. Class A Ordinary Shares

Darkiris Inc is a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games via various third-party digital storefronts. Its activities encompass including game design, programming and graphics, as well as distribution and operation of mobile games on various platforms. Its core product offerings are Games Development; develop, market and distribute its self-developed mobile games; and Games Publishing and Operation. It publish and operate its self-developed mobile games and mobile games it license from other game developers.

Share on Social Networks: